EMEA-001929-PIP01-16

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Brazikumab

Decision numberP/0397/2017
PIP numberEMEA-001929-PIP01-16
Pharmaceutical form(s)Solution for injection; Solution for infusion
Condition(s)/indication(s)

Treatment of ulcerative colitis

Treatment of Crohn's disease

Route(s) of administrationSubcutaneous use; Intravenous use
PIP applicant

Allergan Limited
Tel. +44 1628494026
E-mail: uk_medinfo@allergan.com

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision